Skip to content

Research Categories Archives

FDA to Hold Patient Listening Session for CMT2C/TRPV4 

This October, the FDA will host a Patient Listening Session for the CMT2C/TRPV4 community, organized by CMTA. During this event, the FDA will hear from people living with this form of CMT about their lives, their needs, and their hopes for new treatments.